Cocrystal Pharma Inc (COCP)

NASDAQ
1.2000
+0.1000(+9.09%)
After Hours
1.1600
-0.0400(-3.3333%)
- Real-time Data
  • Volume:
    152,350,935
  • Bid/Ask:
    1.1600/1.1700
  • Day's Range:
    1.1600 - 1.4900

COCP Overview

Prev. Close
1.1
Day's Range
1.16-1.49
Revenue
1.55M
Open
1.38
52 wk Range
0.76-3.46
EPS
-0.17
Volume
152,350,935
Market Cap
116.96M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
18,904,326
P/E Ratio
-
Beta
0.73
1-Year Change
-35.14%
Shares Outstanding
97,468,755
Next Earnings Date
Aug 12, 2021
What is your sentiment on Cocrystal Pharma Inc?
or
Market is currently closed. Voting is open during market hours.

Cocrystal Pharma Inc News

Cocrystal Pharma Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralBuyNeutralStrong Sell
Technical IndicatorsStrong SellStrong SellSellBuySell
SummarySellSellNeutralNeutralStrong Sell

Cocrystal Pharma Inc Company Profile

Cocrystal Pharma Inc Company Profile

Employees
13

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase 2a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections; and drug discovery collaboration with HitGen and InterX Inc. The company is headquartered in Bothell, Washington.

Read More
  • when the report will rise?
    0
    • 1,41 in premarket ? come mai va sempre peggio ?
      0
      • What a pump and dump
        0
        • what did you expect?
          0
      • Cocrystal Pharma Provides Update on its COVID-19 Antiviral Discovery and Development Programs
        0
        • 10$
          1
          • Down down every day 😔
            2
            • not today
              0
          • Any news for forecast?
            0
            • :(
              0
              • stay strong, one day this will jump up 100% and you will forget this volatility, it's not that kind of stock that takes months to grow at a slow pace
                0
              • Jaime Quadralets see but makes me disappointed so far
                0
            • 3$ on sight👀
              1
              • Nice try.....😜😎
                0
                • To whom it may concern, I'm not going to sell.😎😎
                  0
                  • Hold guys good things come to whom wait
                    0
                    • Hold or sold ??
                      0
                      • any news?
                        0
                        • Sold
                          1
                          • Nice symmetrical triangle guys. Tomorrow will aiming high.
                            0
                            • Man this thing goes up and down like crazy. Makes me nuts!
                              0
                              • agree, no way to get a stop loss right...
                                0
                            • Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement (1 hour ago)
                              0
                              • cohen bought in and it has only gone into the stagnant toilet
                                1
                                • Wait.😎
                                  0
                                • Alois Binderyou were right
                                  0
                              • RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
                                0
                                • flying over , this is the game  but i hope the go next year to 5 is a long investing, i buy by 1,3
                                  0
                                  • now is good, plaese go  and go  i wish all a Merry Chrismas and grtaet from 😎Germany
                                    0
                                    • https://www.cocrystalpharma.com/news/press-releases/detail/105/cocrystal-pharma-selects-lead-compound-for-further
                                      0
                                      • good thing I sold this descending pile of garbage
                                        1
                                        • I am definitely not full of it I buy big too big sometimes and chase but that's gambling Saira I'm still your boy
                                          0
                                        • saija
                                          0
                                        • hahahaha hagagaga shorted Moderna novanax bntx winner chicken dinner take your Hyundai for that oil change
                                          0
                                      • makes you wonder what cohen saw in this miserable stock maybe long long term I guess alot of ground to make up
                                        0
                                        • well, curis made 300% in one day without warning or any reason to buy it. if you wanna make profit like this you gotta go to the unknown pennystocks. it's a risk but if you got the right one.....amazon, google tesla etc. got tesla, not cheap enough, still 300%. on this one i got in just for fun with little money i can afford to lose.
                                          0
                                        • I fully get your thinking if you are not willing to take risk for big gains then you cannot afford to lose
                                          0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.